Albright Hereditary Osteodystrophy
- PMID: 32644567
- Bookshelf ID: NBK559141
Albright Hereditary Osteodystrophy
Excerpt
Albright hereditary osteodystrophy (AHO) phenotype was first described in 1942 by Fuller Albright. AHO refers to a constellation of signs, including a round face, short stature with a stocky habitus, brachydactyly, subcutaneous ossification, and dental anomalies. Developmental delay, obesity (early-onset), and relative macrocephaly may be the additional features of AHO.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Mantovani G, Elli FM. Inactivating PTH/PTHrP Signaling Disorders. Front Horm Res. 2019;51:147-159. - PubMed
-
- Mouallem M, Shaharabany M, Weintrob N, Shalitin S, Nagelberg N, Shapira H, Zadik Z, Farfel Z. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf) 2008 Feb;68(2):233-9. - PubMed
-
- Wilson LC, Hall CM. Albright's hereditary osteodystrophy and pseudohypoparathyroidism. Semin Musculoskelet Radiol. 2002 Dec;6(4):273-83. - PubMed
Publication types
LinkOut - more resources
Full Text Sources